AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11497535
Drug: Conjugated estrogens,
RxNorm normalized name: synthetic conjugated estrogens, A
DrugBank: Synthetic Conjugated Estrogens, A (DB09317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens, 0.625 mg/d, plus trimonthly medroxyprogesterone acetate, 5 mg/d for 13 days (n = 45)
Trial: 9504447
Drug: Dietary therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary therapy with participant selected diet
Trial: 8040666
Drug: CT/RT (chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT/RT (chemotherapy with radiotherapy)
Trial: 28646887
Drug: Intravenous tissue
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tissue plasminogen activator (tPA) 4 mg followed by dornase alfa 5 mg, administered once daily for 3 days.
Trial: 28646887
Drug: Placebo (tPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (tPA 4 mg followed by normal saline), administered once daily for 3 days.
Trial: 24249853
Drug: Advanced pharmacy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced pharmacy practice experience (APPE) in medication therapy management (MTM)
Trial: 17333792
Drug: Albendazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (400 mg, once daily for 5 days)
Trial: 17333792
Drug: Metronidazole (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (250 mg, 3 times a day for 5 days)
Trial: 11566458
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg orally every 12 hours for 5 days)
Trial: 9036746
Drug: Standard-dose heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose heparin (100 U/kg bolus)
Trial: 9036746
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (70 U/kg bolus)
Trial: 9036746
Drug: Early sheath
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early sheath removal (heparin stopped after procedure)
Trial: 9036746
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of low-dose heparin and early sheath removal
Trial: 9036746
Drug: Late sheath
RxNorm normalized name: SHEATH,LATEX LARGE UROCARE #500335
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late sheath removal (heparin continued for 12 hours)
Trial: 8342759
Drug: Fixed CPB
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed CPB flow of 2.4 l.m-2
Trial: 3296129
Drug: Oral thromboxane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral thromboxane synthetase inhibitor (TSI)
Trial: 30392388
Drug: Exercise group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise group (4-month concurrent training, 3 days/week, 60 min/session)
Trial: 26621631
Drug: BB-12 given
RxNorm normalized name: rPDGF-BB
DrugBank: Becaplermin (DB00102)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BB-12 given in capsule form
Trial: 22075942
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg DIM daily for 6 months
Trial: 17621671
Drug: Reduced-dose sirolimus-eluting
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Reduced-dose sirolimus-eluting stents (SESs)
Trial: 11982448
Drug: Olanzapine 7.5
RxNorm normalized name: olanzapine 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 7.5 mg
Trial: 11982448
Drug: Olanzapine 10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10.0 mg
Trial: 11982448
Drug: Haloperidol 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 7.5 mg
Trial: 10596656
Drug: Topical anesthetic
RxNorm normalized name: Topical anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical anesthetic ointment of Xylocaine 5%
Trial: 15714749
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of anticoagulants with antiplatelet agents with rheological effects (piracetam, buflomedil, pentoxifylline)
Trial: 15714749
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of anticoagulants with dipyridamole (antiplatelet agent without rheological effects)
Trial: 2065391
Drug: JWYY tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JWYY tablets
Trial: 675836
Drug: Topical diethylcarbamazine
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical diethylcarbamazine citrate (DEC) applied daily
Trial: 675836
Drug: Weekly topical
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly topical applications of DEC emulsion
Trial: 675836
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of diethylcarbamazine citrate (DEC)
Trial: 31818845
Drug: Intraperitoneal irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal irinotecan added to standard systemic therapy (5-fluorouracil/leucovorin with oxaliplatin and bevacizumab)
Trial: 31818845
Drug: Standard systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard systemic therapy (5-fluorouracil/leucovorin with oxaliplatin and bevacizumab)
Trial: 28994364
Drug: Sildenafil (1-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (1-3 mg/kg/day every 8 hours)
Trial: 28994364
Drug: Tadalafil (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil (1 mg/kg once a day)
Trial: 26125945
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered trimethoprim-sulfamethoxazole (TSM)
Trial: 26125945
Drug: Intravenously administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenously administered cefuroxime and metronidazole (CXM)
Trial: 16900802
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of prednisone daily for 5 consecutive days before the operation
Trial: 7729788
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of oral DEX
Trial: 7041450
Drug: Extra-amniotic prostaglandin
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra-amniotic prostaglandin E2 gel
Trial: 7041450
Drug: Amniotomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amniotomy with or without intravenous oxytocin
Trial: 7041450
Drug: Extra-amniotic PGE2
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra-amniotic PGE2 gel plus an indwelling catheter
Trial: 27633250
Drug: Sembragiline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sembragiline (1 mg daily)
Trial: 27633250
Drug: Sembragiline (lower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sembragiline (lower doses)
Trial: 21733214
Drug: OROS methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS methylphenidate (MPH) 18, 36 or 72 mg/day
Trial: 21673083
Drug: Osteopathic Manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic Manual Therapy (OMT) protocol consisting of myofascial release of the thoracic inlet, pectoral traction, rib raising, thoracic pump, and abdominal pump for 15 minutes.
Trial: 10229464
Drug: Control (observation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (observation without treatment)
Trial: 23363713
Drug: Adding folic
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adding folic acid 5 mg/day and vitamin B(12) 500 µg twice daily (Group 2)
Trial: 23363713
Drug: Adding folic
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adding folic acid 5 mg/day, vitamin B(12) 500 µg twice daily and probucol 500 mg twice daily (Group 3)
Trial: 23363713
Drug: Standard antihypertensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antihypertensive medication (Group 1)
Trial: 20868458
Drug: risperidone (0.5‐2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: risperidone (0.5‐2 mg/day)
Trial: 20868458
Drug: divalproex (60‐120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: divalproex (60‐120 μg/mL)
Trial: 11829701
Drug: eptifibatide (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eptifibatide (two 180‐microg/kg boluses, 10 minutes apart, with a continuous infusion of 2.0 microg/kg per minute; n = 1040)
Trial: 10350964
Drug: Standard services
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard services (treatment-as-usual, TAU)
Trial: 7287240
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg methyldopa (or 500 mg if poor response)
Trial: 31648455
Drug: Analgesic mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic mixture of morphine, ropivacaine, epinephrine, ketorolac and betamethasone
Trial: 27720602
Drug: epinastine 0.05%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: epinastine 0.05% ophthalmic solution
Trial: 22963378
Drug: Exercise intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exercise intervention (in- and outpatient) including strength, flexibility, and aerobic exercise, performed 5 times/week during hospitalization and a combination of supervised and home-based sessions using the Wii device for 10 weeks after discharge.
Trial: 15305311
Drug: GBE-NT (discontinuation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GBE-NT (discontinuation group)
Trial: 15305311
Drug: NT-GBE (new
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NT-GBE (new treatment group)
Trial: 15305311
Drug: NT-NT (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NT-NT (no treatment group)
Trial: 9512274
Drug: Prior radiation
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior radiation and/or chemotherapy
Trial: 8062521
Drug: rapeseed oil
RxNorm normalized name: Rapeseed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rapeseed oil mayonnaise with a small dose of sitostanol ester (800 mg/day of sitostanol)
Trial: 8062521
Drug: rapeseed oil
RxNorm normalized name: Rapeseed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rapeseed oil mayonnaise with a higher dose of sitostanol ester (2000 mg/day of sitostanol)
Trial: 3173998
Drug: 10 IU/cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 IU/cc heparin infusion
Trial: 3173998
Drug: 5 IU/cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 IU/cc heparin infusion
Trial: 22512264
Drug: Vildagliptin +
RxNorm normalized name: vildagliptin
DrugBank: Vildagliptin (DB04876)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Vildagliptin + Metformin
Trial: 18172697
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (PT) added to general practitioners' care
Trial: 8222658
Drug: Triphasic oral
RxNorm normalized name: CeeNU, triphasic oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic oral contraceptive containing gestodene
Trial: 8222658
Drug: Triphasic oral
RxNorm normalized name: CeeNU, triphasic oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic oral contraceptive containing norethindrone
Trial: 30125457
Drug: Marine n‐3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marine n‐3 fatty acids (2.6 g daily for 44 weeks)
Trial: 23351923
Drug: Conservative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative therapy (CO)
Trial: 19287306
Drug: GSH 1500
RxNorm normalized name: GSH
DrugBank: Glutathione (DB00143)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSH 1500 mg/m before oxaliplatin infusion
Trial: 19287306
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution before oxaliplatin infusion (Control)
Trial: 11812711
Drug: Epidural steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural steroid injection with 8 mL of 0.125% bupivacaine and 40 mg of methylprednisolone (20 mg/mL) at a rate of 6 mL/min.
Trial: 11812711
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion pressure measurement in DSD patients before treatment.
Trial: 7555530
Drug: Enalapril (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (mean daily dose 35 +/- 11.4 mg)
Trial: 7555530
Drug: Nifedipine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (mean daily dose 50 +/- 12.9 mg)
Trial: 7371971
Drug: Paper Pill
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper Pill (30 microgram ethinyloestradiol and 150 microgram levonorgestrel)
Trial: 7371971
Drug: Microgynon 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microgynon 30 (conventional tablet formulation)
Trial: 28844318
Drug: SQ tree
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ tree SLIT-tablet (1 to 24 development units, DU)
Trial: 28844318
Drug: SQ tree
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ tree SLIT-tablet (12 and 24 DU)
Trial: 24047236
Drug: Training program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training program (Staff as Change Agents - Enhancing and Sustaining Mental Health in Aged Care)
Trial: 16553019
Drug: Tiagabine 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiagabine 6 mg
Trial: 17557435
Drug: Tiagabine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiagabine 10 mg
Trial: 15058157
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine premedication (0.15 mg)
Trial: 15058157
Drug: Intramuscular clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular clonidine premedication (0.15 mg)
Trial: 15058157
Drug: Placebo (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral or intramuscular)
Trial: 15058157
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and intramuscular clonidine
Trial: 15058157
Drug: Intramuscular clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular clonidine
Trial: 11011346
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg/d for 8 weeks
Trial: 11011346
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg/d plus Enalapril 5 mg/d for 8 weeks
Trial: 11011346
Drug: Enalapril 5
RxNorm normalized name: enalapril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 5 mg/d for 8 weeks
Trial: 11011346
Drug: Enalapril 5
RxNorm normalized name: enalapril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 5 mg/d plus Simvastatin 10 mg/d for 8 weeks
Trial: 8800119
Drug: 450 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 mg/day oral propafenone (Group 1)
Trial: 31594876
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg daily for 1 month, followed by 80 mg daily for 23 months)
Trial: 24261227
Drug: Adaptol 1500-2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adaptol 1500-2000 mg/day for 30+2 days
Trial: 18392690
Drug: pioglitazone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pioglitazone (30 mg/day; n = 14)
Trial: 18392690
Drug: rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosiglitazone (4 mg/day; n = 11)
Trial: 18392690
Drug: placebo (medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo (medical nutrition therapy; n = 10)
Trial: 12837435
Drug: tadalafil 20
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tadalafil 20 mg
Trial: 10440425
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg once daily for 7 days
Trial: 12396958
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment for 7 days
Trial: 10440425
Drug: Nifedipine (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (calcium uptake antagonist)
Trial: 8646251
Drug: dexfenfluramine (dF)
RxNorm normalized name: dexfenfluramine
DrugBank: Dexfenfluramine (DB01191)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexfenfluramine (dF) 30 mg/day
Trial: 1349486
Drug: sustained-release verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sustained-release verapamil 200 mg b.i.d.
Trial: 1349486
Drug: conventional verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: conventional verapamil 120 mg t.i.d.
Trial: 3972657
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose rate radiotherapy
Trial: 3972657
Drug: Conventionally fractionated
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventionally fractionated irradiation at normal high dose rate
Trial: 31181022
Drug: EMLA patch
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA patch (standard care)
Trial: 20393347
Drug: Extended buprenorphine/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended buprenorphine/naloxone therapy (BUP) for 12 weeks
Trial: 18350637
Drug: Esomeprazole enteric-coated
RxNorm normalized name: esomeprazole
DrugBank: Esomeprazole (DB00736)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Esomeprazole enteric-coated capsules (40 mg)
Trial: 18350637
Drug: Esomeprazole magnesium
RxNorm normalized name: Esomeprazole Magnesium
DrugBank: Esomeprazole (DB00736)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Esomeprazole magnesium (40 mg)
Trial: 12075272
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (6 1-g capsules providing 3 g eicosapentaenoic acid and 2.1 g docosahexaenoic acid/d)
Trial: 29603547
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (CGM and standard treatment)
Trial: 18446021
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of ascorbic acid and 400 IU of alpha-tocopherol for 6 months
Trial: 18446021
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg of ascorbic acid and 400 IU of alpha-tocopherol for 6 months
Trial: 12881451
Drug: Xuezhikang (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuezhikang (1200 mg daily)
Trial: 11254068
Drug: Home-based multisystemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based multisystemic therapy (MST)
Trial: 30550982
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplements (16 weeks)
Trial: 26312616
Drug: 30 min
RxNorm normalized name: Goddess Garden SPF 30 Mineral Sunscreen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 min of the Stroop task (mentally fatiguing treatment)
Trial: 26312616
Drug: 30 min
RxNorm normalized name: Goddess Garden SPF 30 Mineral Sunscreen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 min of reading magazines (control treatment)
Trial: 22261578
Drug: Conjugated linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated linoleic acid (CLA) supplementation (1.7 g of cis-9,trans-11 and trans-10,cis-12 CLA in 200 mL of sterilized milk twice daily for 12 weeks)
Trial: 22261578
Drug: Placebo (salad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (salad oil in 200 mL of sterilized milk twice daily for 12 weeks)
Trial: 17484381
Drug: Test food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test food (40 mg of soy isoflavone aglycone per day)
Trial: 11932472
Drug: Sulindac (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac (75 or 150 mg orally twice a day for 48 months)
Trial: 11932472
Drug: Placebo (identical-appearing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical-appearing tablets for 48 months)
Trial: 9751323
Drug: Mitoxantrone in
RxNorm normalized name: Mitoxantrone Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitoxantrone in combination with steroids
Trial: 9751323
Drug: Secondary hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Secondary hormonal therapies (alternative antiandrogens and anti‐adrenal agents)